Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of Doses
Clinical trial NCT02467270 · COMPLETED
Trial details
- NCT number
- NCT02467270
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-13
- Primary completion
- 2020-04-29
- Enrollment
- 283
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.